34 min listen
Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?
Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?
ratings:
Length:
13 minutes
Released:
Aug 13, 2020
Format:
Podcast episode
Description
The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19. David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19. Related Article(s): Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
Released:
Aug 13, 2020
Format:
Podcast episode
Titles in the series (100)
Diagnosing Infectious Mononucleosis: Mononucleosis is a common disease of young adults manifested by lethargy, fever, pharyngitis, lymphadenopathy and splenomegaly. In this podcast, we review the clinical features of the disease and how good each of them is at establishing a diagnosis of... by JAMA Clinical Reviews